Sign inJoin waitlistJoin the waitlist

Anne O'Dea

Medical Director, Breast Cancer Survivorship · University of Kansas School of Medicine

Credentials: · · · ·

History

Breast Cancer Survivorship · University of Kansas School of Medicine
Present

Hematology and Medical Oncology
University of Kansas School of Medicine
2007–2010
University of Kansas School of Medicine
Internal Medicine
University of Kansas School of Medicine
2004–2007
Univ of Kansas Sch of Med
2000–2004

Research

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal…
Journal of Clinical Oncology · 2023 · 183 citations
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial
JAMA Oncology · 2024 · 162 citations
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer
Breast Cancer Research and Treatment · 2010 · 130 citations

Priyanka Sharma
17 papers
Qamar Khan
17 papers
Lauren Nye
10 papers
Shane Stecklein
6 papers
Gregory Crane
5 papers
Jamie Wagner
5 papers
ME
Manana Elia
5 papers
CB
Christa Balanoff
4 papers
Kelsey Larson
4 papers · 1 as a resident
Amanda Amin
3 papers · 2 as a resident
Carol Fabian
3 papers
Deepti Satelli
3 papers

Clinical trials

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2017–2027